💊 Methylergometrine 0.125mg – Controlled Uterine Contraction for Safer Recovery
🔬 What is Methylergometrine 0.125mg?
Methylergometrine (also called Methylergonovine) is a semi-synthetic ergot alkaloid used primarily in obstetrics. Each tablet contains 0.125mg of methylergometrine maleate. It acts directly on uterine smooth muscle to produce sustained uterine contractions, aiding in the prevention and treatment of postpartum bleeding.
Its vasoconstrictive and oxytocic properties make it essential in managing uterine atony, one of the major causes of postpartum hemorrhage (PPH).
✅ Uses / Indications
Methylergometrine 0.125mg is indicated for:
-
Prevention and treatment of postpartum hemorrhage (PPH) due to uterine atony
-
Management of uterine involution after childbirth
-
Adjunct treatment in cases of incomplete abortion
-
Occasionally used in gynecological procedures requiring uterine contraction
This medication is typically used post-delivery, either orally or via injection, under medical supervision.
🧪 Composition / Ingredients
Each oral tablet contains:
-
Methylergometrine maleate 0.125mg (equivalent to 0.1mg base)
-
Excipients may include: Lactose, microcrystalline cellulose, magnesium stearate, corn starch, and coloring agents (depending on the manufacturer)
⚠️ Precautions and Warnings
-
Hypertension: Contraindicated in women with high blood pressure, preeclampsia, or eclampsia.
-
Vascular disease: Should not be used in patients with coronary artery disease or peripheral vascular disease.
-
Liver or kidney impairment: Use cautiously or avoid, as methylergometrine is metabolized hepatically and excreted renally.
-
Sepsis or infections: Not advised if sepsis is present, due to risk of vasoconstriction-induced ischemia.
-
Breastfeeding: Enters breast milk—monitor for side effects in infants; temporary discontinuation may be advised.
💥 Side Effects
Common:
-
Nausea and vomiting
-
Headache
-
Dizziness
-
Abdominal cramps
Less Common but Serious:
-
Hypertensive crisis
-
Chest pain or myocardial ischemia
-
Peripheral vasospasm
-
Seizures
-
Visual disturbances
Seek immediate medical attention for chest tightness, sudden vision changes, or limb pain/swelling.
📋 Dosage and Administration
-
Oral dose: Typically 0.125mg two to four times daily for up to 1 week post-delivery.
-
May also be administered intramuscularly (IM) or intravenously (IV) in emergencies (by a healthcare professional only).
-
Best taken after delivery of the placenta under medical supervision.
🔄 Drug Interactions
-
Other vasoconstrictors (e.g., triptans, sympathomimetics): Increased risk of hypertension or ischemia
-
CYP3A4 inhibitors (e.g., erythromycin, ketoconazole): May increase methylergometrine levels, heightening side effect risk
-
HIV protease inhibitors: Concomitant use is contraindicated due to dangerous vasospasm and ischemia risk
Always inform the provider of all current medications, including herbal supplements.
📌 Conclusion
Methylergometrine 0.125mg plays a critical role in postpartum hemorrhage control and uterine tone restoration. While highly effective, it should only be used under careful medical supervision due to potential vascular and hypertensive side effects. Proper screening for contraindications is essential before administration.
Note: This information is intended for educational purposes and should not replace professional medical advice. Always consult a healthcare provider for personalized guidance.
Reviews
There are no reviews yet.